Biological Products, (No Diagnostic Substances) · X0 · CIK 1671927
Immunocore Holdings plc develops and commercializes T-cell receptor-based therapies
Comparable business profile · signals at a glance
In the 90 days to Feb 18, 2026: 4 sold $5.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Jallal BahijaCHIEF EXECUTIVE OFFICER | Sell | 11,474 | $32.35 | $371K |
| Feb 18, 2026 | Berman David MHEAD OF R&D | Sell | 5,965 | $32.35 | $193K |
| Feb 18, 2026 | St Leger Tina AmberCHIEF HR OFFICER | Sell | 1,000 | $32.35 | $32K |
| Feb 18, 2026 | Goll JohnSVP, FINANCE & CAO | Sell | 698 | $32.35 | $23K |
| Dec 5, 2025 | Berman David MHEAD OF R&D | Sell | 572 | $40.14 | $23K |
| Dec 4, 2025 | Berman David MHEAD OF R&D | Sell | 31,341 | $40.26 | $1.3M |
| Nov 28, 2025 | Berman David MHEAD OF R&D | Sell | 5,521 | $40.09 | $221K |
| Nov 26, 2025 | Berman David MHEAD OF R&D | Sell | 69,404 | $40.12 | $2.8M |
| Nov 25, 2025 | Berman David MHEAD OF R&D | Sell | 18,020 | $40.03 | $721K |
| Nov 24, 2025 | Berman David MHEAD OF R&D | Sell | 100 | $40.00 | $4K |
| Sep 30, 2025 | Berman David MHEAD OF R&D | Sell | 61,849 | $35.23 | $2.2M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.